Indaptus Therapeutics Files 8-K
Ticker: INDP · Form: 8-K · Filed: Sep 4, 2025 · CIK: 1857044
| Field | Detail |
|---|---|
| Company | Indaptus Therapeutics, INC. (INDP) |
| Form Type | 8-K |
| Filed Date | Sep 4, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, financials
TL;DR
Indaptus Therapeutics filed an 8-K on Sept 4, 2025. No major news, just routine filings.
AI Summary
Indaptus Therapeutics, Inc. filed an 8-K on September 4, 2025, reporting on other events and financial statements. The company, formerly known as Intec Parent Inc. until April 14, 2021, is incorporated in Delaware and headquartered in New York City.
Why It Matters
This filing provides an update on the company's corporate events and financial reporting, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not contain any new material information that would immediately impact the company's risk profile.
Key Numbers
- 001-40652 — SEC File Number (Identifies the company's filing with the SEC.)
- 86-3158720 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Indaptus Therapeutics, Inc. (company) — Registrant
- September 4, 2025 (date) — Date of Report
- Intec Parent Inc. (company) — Former Company Name
- April 14, 2021 (date) — Date of Name Change
- Delaware (jurisdiction) — State of Incorporation
- New York (location) — Principal Executive Offices City
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is to report on 'Other Events' and 'Financial Statements and Exhibits' as of September 4, 2025.
When did Indaptus Therapeutics, Inc. change its name?
The company's name was changed from Intec Parent Inc. on April 14, 2021.
Where is Indaptus Therapeutics, Inc. headquartered?
The company's principal executive offices are located at 3 Columbus Circle, 15th Floor, New York, NY 10019.
What is the company's Standard Industrial Classification (SIC) code?
The SIC code for Indaptus Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the SEC file number for Indaptus Therapeutics, Inc.?
The SEC file number for Indaptus Therapeutics, Inc. is 001-40652.
Filing Stats: 430 words · 2 min read · ~1 pages · Grade level 10.4 · Accepted 2025-09-04 16:01:33
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value INDP Nasdaq Capital Mark
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex99-1.htm (EX-99.1) — 18KB
- ex99-1_001.jpg (GRAPHIC) — 8KB
- 0001493152-25-012630.txt ( ) — 233KB
- indp-20250904.xsd (EX-101.SCH) — 3KB
- indp-20250904_lab.xml (EX-101.LAB) — 33KB
- indp-20250904_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 4, 2025 INDAPTUS THERAPEUTICS, INC. By: /s/ Nir Sassi Name: Nir Sassi Title: Chief Financial Officer